These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 1119822)

  • 1. A new formula for depigmenting human skin.
    Kligman AM; Willis I
    Arch Dermatol; 1975 Jan; 111(1):40-8. PubMed ID: 1119822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical tretinoin, hydroquinone, and betamethasone valerate in the therapy of melasma.
    Gano SE; Garcia RL
    Cutis; 1979 Feb; 23(2):239-41. PubMed ID: 421493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A method for maintaining the clinical results of 4% hydroquinone and 0.025% tretinoin with a cosmeceutical formulation.
    Draelos ZD; Raab S; Yatskayer M; Chen N; Krol Y; Oresajo C
    J Drugs Dermatol; 2015 Apr; 14(4):386-90. PubMed ID: 25844613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical use of hydroquinone for depigmentation.
    Spencer MC
    JAMA; 1965 Nov; 194(9):962-4. PubMed ID: 5897964
    [No Abstract]   [Full Text] [Related]  

  • 5. Usefulness of a narrow-band reflectance spectrophotometer in evaluating effects of depigmenting treatment.
    Yoshimura K; Harii K; Masuda Y; Takahashi M; Aoyama T; Iga T
    Aesthetic Plast Surg; 2001; 25(2):129-33. PubMed ID: 11349303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical use of hydroquinone as a depigmenting agent.
    Arndt KA; Fitzpatrick TB
    JAMA; 1965 Nov; 194(9):965-7. PubMed ID: 5897965
    [No Abstract]   [Full Text] [Related]  

  • 7. The combination of glycolic acid peels with a topical regimen in the treatment of melasma in dark-skinned patients: a comparative study.
    Sarkar R; Kaur C; Bhalla M; Kanwar AJ
    Dermatol Surg; 2002 Sep; 28(9):828-32; discussion 832. PubMed ID: 12269877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating epidermal melasma with a 4% hydroquinone skin care system plus tretinoin cream 0.025%.
    Grimes P; Watson J
    Cutis; 2013 Jan; 91(1):47-54. PubMed ID: 23461059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new bleaching protocol for hyperpigmented skin lesions with a high concentration of all-trans retinoic acid aqueous gel.
    Yoshimura K; Harii K; Aoyama T; Shibuya F; Iga T
    Aesthetic Plast Surg; 1999; 23(4):285-91. PubMed ID: 10441721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cosmetic color improvement of the nipple-areola complex by optimal use of tretinoin and hydroquinone.
    Yoshimura K; Momosawa A; Watanabe A; Sato K; Matsumoto D; Aiba E; Harii K; Yamamoto T; Aoyama T; Iga T
    Dermatol Surg; 2002 Dec; 28(12):1153-7; discussion 1158. PubMed ID: 12472496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of dyschromias in ethnic skin.
    Halder RM; Richards GM
    Dermatol Ther; 2004; 17(2):151-7. PubMed ID: 15113282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermittent therapy for melasma in Asian patients with combined topical agents (retinoic acid, hydroquinone and hydrocortisone): clinical and histological studies.
    Kang WH; Chun SC; Lee S
    J Dermatol; 1998 Sep; 25(9):587-96. PubMed ID: 9798345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of topical retinoids in the treatment of pigmentary disorders: an evidence-based review.
    Kang HY; Valerio L; Bahadoran P; Ortonne JP
    Am J Clin Dermatol; 2009; 10(4):251-60. PubMed ID: 19489658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical chemotherapy of pigment abnormalities in surgical patients.
    Gilchrest BA; Goldwyn RM
    Plast Reconstr Surg; 1981 Apr; 67(4):435-9. PubMed ID: 7208685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Depigmentation for cosmetic purposes: prevalence and side-effects in a female population in Senegal].
    Raynaud E; Cellier C; Perret JL
    Ann Dermatol Venereol; 2001; 128(6-7):720-4. PubMed ID: 11460033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale for the use of topical corticosteroids in melasma.
    Menter A
    J Drugs Dermatol; 2004; 3(2):169-74. PubMed ID: 15098972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of 4% hydroquinone combined with 10% glycolic acid, antioxidants, and sunscreen in the treatment of melasma.
    Guevara IL; Pandya AG
    Int J Dermatol; 2003 Dec; 42(12):966-72. PubMed ID: 14636195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of retinoic acid in the treatment of melasma.
    Pathak MA; Fitzpatrick TB; Kraus EW
    J Am Acad Dermatol; 1986 Oct; 15(4 Pt 2):894-9. PubMed ID: 3534025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience with a strong bleaching treatment for skin hyperpigmentation in Orientals.
    Yoshimura K; Harii K; Aoyama T; Iga T
    Plast Reconstr Surg; 2000 Mar; 105(3):1097-108; discussion 1109-10. PubMed ID: 10724272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethnic considerations in the treatment of Hispanic and Latin-American patients with hyperpigmentation.
    Hexsel D; Arellano I; Rendon M
    Br J Dermatol; 2006 Dec; 156 Suppl 1():7-12. PubMed ID: 17176299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.